Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Pharmacology

Background:

• The antibiotic development pipeline is diminishing, leading to a critical shortage of effective treatments.
• Multidrug-resistant organisms (MDROs) are a growing global challenge, particularly in intensive care units (ICUs) and healthcare-associated infections.
• Inappropriate antimicrobial therapy is a significant predictor of poor outcomes in septic patients.

Purpose of the Study:

• To review the challenges posed by antimicrobial resistance in critically ill patients.
• To highlight the importance of antibiotic stewardship in optimizing antimicrobial use.
• To discuss strategies for improving outcomes and reducing resistance in ICUs.

Main Methods:

• Review of current literature on antibiotic pipeline, antimicrobial resistance, and antibiotic stewardship.
• Focus on critically ill patients and healthcare-associated infections.
• Analysis of guidelines and strategies for optimizing antibiotic therapy.

Main Results:

• The decline in antibiotic development is multifactorial, exacerbating the challenge of MDROs.
• Antibiotic stewardship guidelines, such as those from the Surviving Sepsis Campaign, aim to optimize antibiotic selection, dosage, and duration.
• Pharmacokinetically/pharmacodynamically optimized dosing is recommended empirically and adjusted based on pathogen susceptibility and clinical response.

Conclusions:

• Effective antibiotic stewardship is essential for managing multidrug-resistant organisms in critically ill patients.
• Optimized dosing regimens and local stewardship practices are key to improving outcomes and combating resistance.
• Addressing the declining antibiotic pipeline is crucial for future infectious disease management.